Terrance Mayes, Loretta Erhunmwunsee named leaders of NCCN Forum on Equity

NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer

The NCCN added MammaPrint + BluePrint to the Clinical Practice Guidelines in Oncology for the identification of a subset of hormone receptor positive, HER2-negative early-stage breast cancer patients most likely to benefit from anthracycline-based chemotherapy.

February 06, 2026

Vol.52 No.05

Drugs & Targets

Trodelvy added to NCCN guidelines as preferred regimen option for first-line metastatic TNBC

Trodelvy (sacituzumab govitecan-hziy) was added to the NCCN Guidelines as a category 1 preferred first-line treatment option for people with metastatic triple-negative breast cancer whose disease is PD-L1 negative (CPS <10) and no germline BRCA1/2 PV.

January 30, 2026

Vol.52 No.04

In Brief

Renuka Iyer named chief medical officer for NCCN

Renuka Iyer was appointed chief medical officer for the National Comprehensive Cancer Network—an alliance of leading cancer centers that publishes free evidence-based, expert consensus-driven guidelines for cancer prevention and care.

December 12, 2025

Vol.51 No.45

In Brief

Arjan Gower receives NCCN grant to study a targeted therapy for early-stage NSCLC with rare EGFR mutations

Arjan Gower, a hematologist/oncologist at the UCLA Health Jonsson Comprehensive Cancer Center, received a $950,000 grant from the National Comprehensive Cancer Network and Taiho Oncology Inc. to help launch a multi-institutional clinical trial to test zipalertinib, an investigational drug that targets specific EGFR mutations, including Exon 20 insertions, which are known to drive cancer growth and resist standard treatments.

July 11, 2025

Vol.51 No.27

Clinical Roundup

NCCN announces virtual tool for navigating guidelines

The National Comprehensive Cancer Network announces a new, interactive digital delivery format for the NCCN Clinical Practice Guidelines in Oncology.

June 27, 2025

Vol.51 No.25

In Brief

The Clinic by Cleveland Clinic expands Cancer Concierge

The Clinic by Cleveland Clinic announced the expansion of Cancer Concierge by Cleveland Clinic—a program connecting cancer patients across the U.S. with oncology subspecialists.

June 20, 2025

Vol.51 No.24

Terrance Mayes, Loretta Erhunmwunsee named leaders of NCCN Forum on Equity

YOU MAY BE INTERESTED IN

NCCN updates guidelines recognizing MammaPrint to guide personalized anthracycline use in HR+/HER2- early‑stage breast cancer

Trodelvy added to NCCN guidelines as preferred regimen option for first-line metastatic TNBC

Renuka Iyer named chief medical officer for NCCN

Arjan Gower receives NCCN grant to study a targeted therapy for early-stage NSCLC with rare EGFR mutations

NCCN announces virtual tool for navigating guidelines

The Clinic by Cleveland Clinic expands Cancer Concierge

Renew today!

Subscriber content

Never miss an issue!

Login